Terry Kelly, PhD

Chief Innovation Officer
Volition America
Carlsbad, California, United States

Terry Kelly, PhD is the Chief Scientific Officer for Volition America and Chief Innovation Officer for Volition Rx. She reveived her Ph.D in Neuroscience from UCLA followed by a post-doctoral fellowship in the lab of Peter Jones at USC Norris Cancer Hospital. She has worked at seveal epigenetics and clinical companies and currently leads the Innovation lab based in San Diego, California where her lab studies Neutrophils and molecular mechanisms underlying NETosis.

Presentation(s):

• PB0878 - Physiologically Relevant NETosis Induction Reveals Distinct Triggers and Chromatin Changes

  Monday, June 24, 2024
  13:45 – 14:45 ICT